Oxford Bioscience Partners

Suggest edits

Follow us

Also headquartered in Boston

Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 12

Portfolio

Portfolio Tracker

Add info

Alantos Pharmaceuticals

Pharmaceuticals

Total funding
$20M in 2 rounds from 6 investors

By Oxford Bioscience Partners
$20M Series B in Mar, 2005

Exit Amgen Inc., Jun 6, 2007

AVEO Pharmaceuticals

Biotechnology

Total funding
$120.7M in 3 rounds from 8 investors

By Oxford Bioscience Partners
$42.7M Series B in Oct, 2003

Cambrios

Nanotechnology

Total funding
$30.4M in 3 rounds from 14 investors

By Oxford Bioscience Partners
$14.5M Series D in Nov, 2009

CardioFocus

Biotechnology +2

Total funding
$109.2M in 7 rounds from 11 investors

By Oxford Bioscience Partners
$2.4M Debt financing in May, 2014

Claros Diagnostics

Health Care

Total funding
$4M in 1 rounds from 4 investors

By Oxford Bioscience Partners
$4M Series B in Mar, 2009

Exit OPKO Health, Inc., Oct 13, 2011

Dicerna Pharma

Health Care +1

Total funding
$258M in 4 rounds from 14 investors

By Oxford Bioscience Partners
$60M Series C in Jul, 2013

Glori Energy Inc.

Clean Technology

Total funding
$20M in 2 rounds from 6 investors

By Oxford Bioscience Partners
$20M Series C in Jan, 2012

Seahorse Bioscience

Biotechnology +1

Total funding
$15.4M in 2 rounds from 8 investors

By Oxford Bioscience Partners
$6M Series D in Mar, 2009

Tragara Pharma

Biotechnology

Total funding
$5M in 1 rounds from 5 investors

By Oxford Bioscience Partners
$5M Series B in Apr, 2010

Want to see the complete list?
Go Pro!

Index

By TNW